We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
DELISTED
HilleVax
HLVX
| $449K | ﹤0.01% |
27,000
| – | – |
2023 Q4
1 quarter
|
|
877
Quanterix
QTRX
$145M
| $444K | ﹤0.01% |
+18,837
| New | +$467K |
2024 Q1
0 quarters
|
|
878
Sunstone Hotel Investors
SHO
$2.21B
| $432K | ﹤0.01% |
38,786
-2,606
| -6% | -$28.5K |
2019 Q4
17 quarters
|
|
879
Aecom
ACM
$7.6B
| $429K | ﹤0.01% |
4,370
-140
| -3% | -$12.7K |
2023 Q4
1 quarter
|
|
880
NetEase
NTES
$81.4B
| $428K | ﹤0.01% |
4,139
-6,189
| -60% | -$633K |
2017 Q3
26 quarters
|
|
881
Douglas Emmett
DEI
$1.61B
| $420K | ﹤0.01% |
30,297
-1,605
| -5% | -$22K |
2017 Q3
26 quarters
|
|
882
Universal Health Realty Income Trust
UHT
$531M
| $413K | ﹤0.01% |
11,258
-2,412
| -18% | -$95.7K |
2023 Q4
1 quarter
|
|
883
Endava
DAVA
$109M
| $397K | ﹤0.01% |
10,436
-159,115
| -94% | -$9.57M |
2020 Q1
16 quarters
|
|
884
Sutro Biopharma
STRO
$190M
| $392K | ﹤0.01% |
6,939
| – | – |
2023 Q4
1 quarter
|
|
885
Four Corners Property Trust
FCPT
$2.39B
| $389K | ﹤0.01% |
15,877
-647
| -4% | -$15.6K |
2021 Q2
11 quarters
|
|
886
CNA Financial
CNA
$12.8B
| $387K | ﹤0.01% |
8,527
+75
| +0.9% | +$3.31K |
2023 Q4
1 quarter
|
|
887
Urban Edge Properties
UE
$2.44B
| $380K | ﹤0.01% |
22,024
-861
| -4% | -$14.9K |
2021 Q1
12 quarters
|
|
888
Canadian National Railway
CNI
$72.9B
| $354K | ﹤0.01% |
2,687
-16,613
| -86% | -$2.12M |
2022 Q1
8 quarters
|
|
889
RLJ Lodging Trust
RLJ
$1.77B
| $349K | ﹤0.01% |
29,495
+1,306
| +5% | +$15.4K |
2020 Q4
13 quarters
|
|
890
Pebblebrook Hotel Trust
PEB
$2.18B
| $348K | ﹤0.01% |
22,553
-1,090
| -5% | -$17.2K |
2021 Q1
12 quarters
|
|
891
Dell
DELL
$301B
| $346K | ﹤0.01% |
3,034
-38
| -1% | -$3.55K |
2023 Q3
2 quarters
|
|
892
Amylyx Pharmaceuticals
AMLX
$3.47B
| $336K | ﹤0.01% |
118,247
-77,246
| -40% | -$1.01M |
2023 Q4
1 quarter
|
|
893
HF Sinclair
DINO
$22.2B
| $321K | ﹤0.01% |
5,323
-18
| -0.3% | -$1.02K |
2023 Q1
4 quarters
|
|
894
Erie Indemnity
ERIE
$12.5B
| $317K | ﹤0.01% |
790
-153
| -16% | -$56.3K |
2023 Q2
3 quarters
|
|
895
Nkarta
NKTX
$138M
| $313K | ﹤0.01% |
28,988
| – | – |
2023 Q4
1 quarter
|
|
896
DELISTED
Liberty Broadband Class A
LBRDA
| $310K | ﹤0.01% |
5,427
+23
| +0.4% | +$1.52K |
2023 Q1
4 quarters
|
|
897
Community Health Systems
CYH
$422M
| $309K | ﹤0.01% |
88,335
| – | – |
2023 Q4
1 quarter
|
|
898
InvenTrust Properties
IVT
$2.33B
| $309K | ﹤0.01% |
12,005
-489
| -4% | -$12.3K |
2021 Q4
9 quarters
|
|
899
Acadia Realty Trust
AKR
$2.54B
| $307K | ﹤0.01% |
18,049
+916
| +5% | +$15.4K |
2021 Q2
11 quarters
|
|
900
Praxis Precision Medicines
PRAX
$6.93B
| $305K | ﹤0.01% |
+4,999
| New | +$224K |
2024 Q1
0 quarters
|
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.